The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback